Document is current
Any future updates will be listed below
-
Authors
Cornman, Hannah L.
Alphonse, Martin P.
Dykema, Arbor
Kollhoff, Alexander L.
Lee, Kevin K.
Manjunath, Jaya
Ma, Emily Z
Parthasarathy, Varsha
Deng, Junwen
Pritchard, Thomas
Kambala, Anusha
Marani, Melika
Parr, Kayla A.
Mohammed, Javid P.
Kwatra, Madan M.
Bream, Jay H.
Ho, Won Jin
Kwatra, Shawn G.
-
Funding
Funding for this research was provided by:
National Institutes of Health (K23AR077073)
- License Information
-
More Information
Article History
Received: 17 January 2024
Accepted: 25 November 2024
First Online: 14 January 2025
Declarations
:
: Dr. Shawn Kwatra is an advisory board member/consultant for Abbvie, Amgen, Arcutis Biotherapeutics, Aslan Pharmaceuticals, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte Corporation, Johnson & Johnson, Leo Pharma, Novartis Pharmaceuticals Corporation, Pfizer, Regeneron Pharmaceuticals, and Sanofi and has served as an investigator for Galderma, Incyte, Pfizer, and Sanofi. He is also on the Executive Board of the Skin of Color Society. All other authors have no conflicts of interest to report. A provisional patent application (patent no. is 63/422,061) was filed for the workflow used in the creation of this manuscript on November 3, 2022.
